A management plan for patients with suspected focal liver lesions which avoids early biopsy includes routine laboratory investigations, ultrasound scanning, and assessment for evidence of extrahepatic metastases and non-hepatic primary tumours. Angiography and computed tomography may also be indicated, and laparotomy or laparoscopy is undertaken to assess any potentially resectable focal liver lesions. The plan requires modification to suit individual circumstances.
Introduction
The patient with a focal lesion in the liver may present a difficult management problem. Upper abdominal symptoms may lead to the diagnosis but the wider application of ultrasound and more recently computed tomography has identified increasing numbers of patients with no symptoms related to their hepatic lesions. In some cases the cause for liver disease may become rapidly obvious but in many no easy diagnosis can be made and further investigation is required. There is no widely accepted protocol for assessing these lesions, although different algorithms have been suggested.' 2 The variation in quality and availability of different investigations is partly responsible for this lack of uniformity; nevertheless, such shortcomings should not be the rationale for inadequate or inappropriate investigations. In this paper we describe a plan for the assessment of these lesions which aims both at avoiding unnecessary overinvestigation and also at selecting those patients who might benefit from high quality specialist studies. One of the major aims is the avoidance of early biopsy of these lesions as not only is this often unhelpful to the management of these patients but also carries the risk of serious complications and may jeopardise later surgical resection. 
Investigation of a focal liver lesion

Discussion
The main objective of the management plan outlined is to avoid early biopsy of focal hepatic lesions until their nature and extent have been adequately defined, thus preventing both unnecessary complications and jeopardising subsequent potentially curative resection. That complications arise from percutaneous liver biopsy is well documented and a complication rate of roughly 6% has been reported recently. 3 Serious problems requiring surgery occur much less frequently, at least in experienced hands. Though the incidence of early complications, particularly biliary leakage and significant haemorrhage, is known, the extent of tumour dissemination after needle biopsy is uncertain, although there is every reason to suppose that this occurs. Fine needle aspiration cytology appears to carry less risk than needle biopsy'4 and is being successfully used to confirm hepatic malignancy especially with ultrasound guidance, although false negative results occur in up to one third of cases" and an experienced cytologist is required. Even this procedure is not without complications and implantation of tumour in the needle tract has also been reported. '4 The risks of biopsy must be balanced against the potential gains. Blind percutaneous biopsy may miss focal lesions, although biopsies guided by ultrasound or computed tomography are more often successful. Small and possibly unrepresentative or necrotic tissue specimens may be obtained by needle biopsy and lead to difficulties in histological or cytological interpretation. Benign tissue may be obtained from a tumour in which malignant change has occurred. Such inadequate or unrepresentative biopsy specimens may delay the recognition of early hepatic malignancies and thus prevent potentially curative resection or other appropriate specific treatment. The pathological report of preoperative biopsy specimens rarely influences the surgical approach to a potentially resectable focal lesion. Biopsy of a focal liver lesion may reveal definite evidence of a secondary tumour deposit despite the absence of any other evidence of a primary tumour; such a finding is uncommon in our practice, although this may be partly due to selection before referral. Nevertheless, even definite biopsy evidence of a metastatic tumour is not necessarily a contraindication to resection of a solitary secondary deposit. 16 The major benefit of a percutaneous biopsy of a solitary liver lesion would be the avoidance of any subsequent surgery. This benefit might be thought to be particularly relevant to benign tumours, which consist largely of haemangiomas, focal nodular hyperplasia, and liver cell adenomas. Haemangiomas will usually have a characteristic appearance on computed tomography or angiography, but this is not always the case and subsequent visual inspection is sometimes necessary to confirm the diagnosis and percutaneous biopsy is obviously contraindicated. Focal nodular hyperplasia is often difficult to confirm histologically with needle biopsy but may be diagnosed on open incision biopsy after visual inspection at operation; excision is not usually necessary. '6 Liver cell adenomas, which are closely associated with use of the oral contraceptive pill,7 may be biopsied and their progress followed after cessation of all hormone treatment.'8 Nevertheless, as these adenomas may bleed, suffer necrosis, or occasionally undergo malignant change resection is desirable in most cases. 16 Thus direct inspection of benign tumours is often indicated and resection not infrequently required.
It seems prudent to carry out percutaneous biopsy of a solid hepatic tumour only when there is evidence of primary tumour at another site, secondary spread from the hepatic primary tumour, tumour irresectability (see below), cirrhosis, or other concomitant disease which precludes hepatic resection. Even in such cases biopsy is indicated only when pathological confirmation of tumour is required. There is a risk that multiple haemangiomas may occasionally be mistaken for secondary tumour deposits, and this possibility should be considered before percutaneous biopsy. Computed tomography or angiography will usually resolve this difficulty. Solitary hepatic tumours presumed to arise from resected colonic carcinomas should be assessed in a similar way to primary liver lesions since hepatic resection is worthwhile in these patients. 16 Multiple colonic secondary deposits or multifocal primary malignancies confined to one hepatic lobe may occasionally be resected, but are usually considered a contraindication to surgery. Though some agree with this cautious approach to solitary hepatic lesions,'6 others have advocated percutaneous biopsy at an earlier stage.'2 '9 The criteria for irresectability of hepatic tumours require careful definition. Evidence of deposits in both lobes of the liver, invasion of the portal venous supply to the proposed liver remnant, or venographic evidence of inferior vena caval invasion is normally considered a definite contraindication to resection. Computed tomography may give a misleading impression of extrahepatic spread into adjacent tissues and organs. Large tumours arising from extrahepatic structures may occasionally mimic liver masses.20 Size alone is seldom a contraindication to attempted resection of a primary solitary hepatic lesion, and we have excised several extensive primary hepatomas in young patients who had previously been regarded as inoperable purely on the basis of the extent of primary tumour on computed tomography.
The plan described here has proved a useful guide to our management of focal liver lesions. It is not comprehensive and requires appropriate modification to individual circumstances, but we hope that it will prove helpful to others faced with similar problems.
